|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |
Abstract |
|---|
|
|
|---|
Recent evidence has shown that the inducible form of nitric oxide (NO) synthase (NOS2) has reduced expression in airway epithelia of patients with cystic fibrosis (CF) despite the presence of chronic inflammation. The goal of this paper is to determine whether NOS2 expression is regulated by the presence of functional CF transmembrane conductance regulator (CFTR). Using a human trachea epithelial cell line in
which CFTR activity is blocked by the overexpression of the CFTR regulatory domain, we found that loss of CFTR activity reduces NOS2 messenger RNA expression as determined by reverse transcriptase/polymerase chain reaction and reduces overall NO production compared with mock-transfected controls. An in
vivo model using mice lacking CFTR expression (cftr
/
), wild-type mice (cftr +/+), and cftr
/
mice that have had human CFTR introduced to the intestinal epithelium using the fatty acid binding protein (FABP) promoter (FABP-hcftr) was also examined. Electrical characterization confirmed that FABP-hcftr mice had corrected electrophysiologic properties compared with cftr
/
mice in the ileum, but
FABP-hcftr nasal transepithelial potential difference measurements were identical to cftr
/
values
showing specific intestinal correction. NOS2-specific immunostaining revealed that NOS2 expression is
evident in sections of ileum and nasal epithelium of cftr +/+ mice but is absent in both tissues in cftr
/
mice. FABP-hcftr mice, however, show strong NOS2 staining in epithelial cells of the ileum but reduced
staining in the nasal epithelium, suggesting a CFTR-related influence in the regulation of NOS2 expression in epithelial cells.
| |
Introduction |
|---|
|
|
|---|
It has been shown that the inducible form of nitric oxide (NO) synthase (NOS2) is expressed constitutively in normal human airway epithelium (1). Recent evidence suggests that this constitutive expression of NOS2 messenger RNA (mRNA) and protein are decreased in airway epithelial cells that are lacking either expression or function of the cystic fibrosis (CF) transmembrane conductance regulator (CFTR) (2, 3). The potential consequences of the loss of epithelial NOS2 expression include diminished antibacterial defenses and altered transepithelial ion transport regulation (4, 5). It is unclear, however, why NOS2 expression is reduced in CF epithelial cells, especially given the inflammatory nature of CF. An issue that needs to be addressed in relation to decreased NOS2 expression in CF airway epithelium is whether NOS2 expression is altered by the presence of active CFTR.
CFTR has been shown to influence a variety of cellular functions both directly and indirectly. Primarily, CFTR has been shown to regulate transepithelial ion transport by influencing the activity of other ion channels such as the epithelial sodium channel (ENaC) (6, 7), the outwardly rectifying chloride channel (ORCC) (8), and the inwardly rectifying potassium channel (ROMK2) (9). Proposed mechanisms for CFTR-dependent regulation of these channels include direct interaction between CFTR and ENaC (6), direct interaction of the nucleotide binding fold-1 of CFTR and ROMK2 (9), and the facilitation of adenosine triphosphate (ATP)-dependent stimulation of ORCC activity by CFTR-mediated ATP release (8).
Because NO production has been shown to effectively
influence both transepithelial chloride and sodium transport in several systems (4, 5, 10), it is plausible that CFTR
conveys some regulation to NOS2 production to further
regulate basal ion transport properties. To begin identifying mechanisms involved in reduced NOS2 expression in
CF airway epithelia despite chronic inflammation, it must
be determined first whether NOS2 expression is altered by
the presence of CFTR activity. The goal of this paper is to
exploit two model systems of CF to determine the influence of CFTR function and expression on NOS2 production. First, a human tracheal epithelial cell line (9/HTEo-)
that has been stably transfected to overexpress the CFTR
regulatory (R) domain, resulting in blocked CFTR-mediated chloride transport (11), was studied to directly measure NOS2 mRNA levels and NO production. Second, an
in vivo model consisting of mice deficient in CFTR expression (cftr
/
), wild-type mice (cftr +/+), and cftr
/
mice that have had human CFTR introduced to the intestinal epithelium using the fatty acid binding protein (FABP)
promoter (FABP-hcftr) (12) was utilized to examine the
effects of differential CFTR expression on NOS2 production in separate tissues of the same animal.
| |
Materials and Methods |
|---|
|
|
|---|
Cell Culture
9/HTEo- cells overexpressing the CFTR R domain (pCEP-RF) and mock-transfected 9/HTEo- cells (pCEP2) were a generous gift from the lab of Dr. Pamela B. Davis, Case Western Reserve University, Cleveland, OH. Cells were cared for as previously described (11). Briefly, 9/HTEo- cells were grown at 37°C in 95% O2/5% CO2 to confluency in Dulbecco's modified Eagle's medium with 10% fetal bovine serum, L-glutamine (2.5 mM), and hygromycin (150 µg/ml) on Vitrogen-coated, 30-mm tissue culture plates.
Mice
Mice lacking CFTR expression (CFTRtm1Unc) and FABP-hcftr mice (CFTRtm1Unc-TgN[FABPCFTR]#Jaw) were obtained from Jackson Laboratories (Bar Harbor, ME). The
cftr +/+ mice were siblings of cftr
/
mice. All mice used
were between 10 and 12 wk of age. CF mice were fed a liquid
diet as described by Eckman and colleagues (13). Mice were
cared for in accordance with Case Western Reserve University IACUC guidelines by the CF Animal Core Facility.
Reverse Transcriptase/Polymerase Chain Reaction Analysis of NOS2 mRNA Expression
Total RNA from 9/HTEo- pCEP2 and pCEP-RF cell lines
was isolated by phenol guanidine-isothiocyanate extraction using TRIzol Reagent (Life Technologies, Inc., Gaithersburg, MD) according to manufacturer's protocol. RNA
was stored at
80°C until used. Total RNA was reverse
transcribed to complementary DNA (cDNA) at 42°C for
1 h. In a 20-µl volume, the reverse transcriptase (RT) reaction included 1 mM of each deoxynucleotide triphosphate (dNTP), 18 mM Tris-HCl, 45 mM KCl, 0.1 mg/ml bovine
serum albumin, 40 units ribonuclease inhibitor, 100 pmol
random hexamers, 2.5 mM MgCl2, 200 units Moloney murine leukemia virus (M-MLV) RT, and 0.3 µg total RNA.
cDNA was amplified by polymerase chain reaction (PCR)
in a 50-µl volume containing 0.5 mM of each dNTP, 20 mM Tris-HCl, 50 mM KCl, 1.2 µM of each NOS2 primer
or 200 nM of each glyceraldehyde-3-phosphate dehydrogenase (GAPDH) primer, 3 mM MgCl2, 2.5 units of Taq
polymerase, and 4 µl cDNA. All reagents were obtained
from Life Technologies, Inc. PCR primer sequences used
were as follows: human NOS2 forward primer: 5'-TCTGTGCCTTTGCTCATGAC-3', human NOS2 reverse primer:
5'-CATGGTGAACACGTTCT TGG-3' (14); GAPDH
forward primer: 5'-CCATGGAGAAGGCTGGGG-3', and
GAPDH reverse primer: 5'-CAAAGTTGTCATGGATGA-3'. The cDNA was denatured for 2 min at 95°C followed by
40 cycles of amplification. Each cycle consisted of denaturation at 95°C for 35 s, annealing at 58°C for 35 s, and primer
extension at 72°C for 45 s. A 30-cycle extension for 5 min
at 72°C followed the 40-cycle program with each cycle consisting of denaturation at 95°C for 1 min, annealing at 62°C for 1 min, and primer extension at 72°C for 90 s. A final extension for 5 min at 72°C followed the 30-cycle program. A
control reaction using GAPDH primers was performed
for each cDNA sample using the respective conditions described previously. Semiquantification of RT-PCR products was accomplished by densitometry using Kodak Digital Science 1D software. RT-PCR reactions were performed
on each sample to amplify both NOS2 and GAPDH message. Quantification of NOS2 message is reported as relative
band intensity compared with GAPDH for each sample.
Direct NO Measurement from 9/HTEo- Cells
For studies of NO production, 9/HTEo- cells (pCEP2 and pCEP-RF) were treated with lipopolysaccharide (LPS) (5 µg/ml) from Pseudomonas aeruginosa (Calbiochem, San Diego, CA) which was added to the media 4 to 5 h before assay. NO assays were performed with an Iso-NO NO meter utilizing the 2 mM Iso-NOP NO sensor (World Precision Instruments, Sarasota, FL). Measurements were taken at 37°C by placing both the NO sensor and samples in an incubator. Data were recorded on a MacLab/4e data acquisition system from Advanced Instruments (Norwood, MD). The Iso-NO meter was calibrated according to manufacturer's instructions using the chemical method of NO production.
Nasal Transepithelial Potential Difference and Short-Circuit Current Measurements
Nasal transepithelial potential difference (TEPD) measurements and short-circuit current (Isc) analysis of transepithelial ion transport were performed as previously described (15).
NOS2-Specific Immunostaining
Nasal epithelium and ileum were excised from cftr
/
,
cftr +/+, and FABP-hcftr mice, paraffin blocked and sectioned as previously described (3). Sections were deparafinized, solubilized in ice-cold methanol for 5 min, and
placed in 2% goat immunoglobulin (Ig) in phosphate-buffered saline (PBS) for 2 h. Antibody against mouse and human NOS2 was obtained from Calbiochem (La Jolla, CA) and incubated with the samples at 4°C overnight at a dilution of 1:300 in PBS. Samples were washed four times in
PBS for 10 min per wash. Goat antirabbit IgG conjugated
to alkaline phosphatase was diluted 1:200 in PBS and incubated with samples for 2 h at 37°C. Samples were washed
as before and stained for 20 min in Vector Red from Novacastra Laboratories Ltd. (Newcastle, UK) according to
manufacturer's instructions and slides were counterstained with hematoxylin. Images were attained using ImagePro
imaging software.
| |
Results |
|---|
|
|
|---|
NOS2 mRNA Expression in 9/HTEo- Cells Overexpressing the CFTR R Domain
To examine the correlation between CFTR function and production of NOS2 mRNA in epithelial cells, a 9/HTEo- cell line model of CF was used. It has previously been shown that overexpression of the CFTR regulatory domain in 9/HTEo- cells blocks basal and cyclic adenosine monophosphate (cAMP)-stimulated chloride secretion through the inhibition of CFTR activity (11, 19). This model system allowed us to determine the effects of lost CFTR function on NOS2 activity and expression in epithelial cells by comparing the R domain expressing 9/HTEo- cells (pCEP-RF) with a mock-transfected control cell line (pCEP2). NOS2 mRNA was essentially undetectable by RT-PCR in pCEP-RF cells, whereas very strong product was obtained with the control pCEP2 cells in both the presence and absence of LPS (5 µg/ml) treatment (Figure 1A). The amount of NOS2 RT-PCR product relative to GAPDH RT-PCR product in each of the cell lines was quantified by measuring band intensity using densitometry (Figure 1B). All samples were treated with LPS to maximize the opportunity for NOS2 mRNA production. With GAPDH intensity set at 1.0, relative NOS2 mRNA product was measured at 0.8 ± 0.2 relative units (n = 14) in pCEP2 9/HTEo- cells, whereas relative band intensity was measured at only 0.1 ± 0.1 relative units (n = 15; P = 0.003) in pCEP-RF 9/HTEo- cells. Although it still remains unclear whether the decreased expression of NOS2 message is due to a lack of transcription or decreased mRNA stability, it is clear that the CF-related phenomenon of decreased epithelial NOS2 protein production originates at the RNA level. These data are consistent with previous findings by Meng and associates (2).
|
NO production was measured in pCEP2 cells and pCEP-RF cells in response to LPS. It was found that pCEP2 cells produce a 4.0 ± 0.4-fold increase in NO production (n = 14); P < 0.00001 compared with basal NO production in pCEP2 cells not treated with LPS (Figure 1C). However, pCEP-RF cells exhibited only a 0.7 ± 0.1-fold increase in NO production (n = 14) under these conditions. Although the RT-PCR data show that NOS2 message is present before stimulation with LPS, actual NO production requires LPS treatment. These data support our hypothesis that the presence of functional CFTR influences NOS2 expression and NO production in response to inflammatory stimuli.
Electrical Characterization of cftr +/+, cftr
/
,
and FABP-hcftr Mice
Responses to chloride-free Ringers and to the adenylate
cyclase agonist forskolin (FSK) were measured by nasal
TEPD in cftr +/+, cftr
/
, and FABP-hcftr mice to determine the level of functional CFTR activity in the nasal
epithelium of these mice. The nasal TEPD in cftr +/+
mice hyperpolarized
10.8 ± 2.1 mV (n = 5) in response
to chloride-free Ringers and further hyperpolarized
3.7 ± 3.3 mV (n = 5) in response to FSK, indicating normal
CFTR activity (16). Nasal TEPD values, however, depolarized in cftr
/
mice in response both to chloride-free
Ringers by 4.4 ± 1.2 mV (n = 4) and to FSK by 0.7 ± 1.8 mV (n = 4), consistent with a lack of functional CFTR.
The nasal TEPD values of FABP-hcftr mice, which have
human CFTR reintroduced into the intestinal epithelium, resemble those of cftr
/
mice. FABP-hcftr nasal TEPD
values further depolarized 3.4 ± 1.5 mV (n= 4) in response to chloride-free Ringers and 2.4 ± 2.8 mV (n = 4)
in response to FSK, suggesting a lack of significant levels
of functional CFTR in the nasal epithelium (Figure 2).
|
To assess the level of CFTR activity in the intestines,
Isc values were measured in response to FSK in cftr +/+,
cftr
/
, and FABP-hcftr mice in sections of ileum (Figure
3). The cftr +/+ mice showed a change in Isc of 37.1 ± 4.0 µA/cm2 (n = 3) in response to FSK, whereas cftr
/
mice had only a
Isc of 1.6 ± 0.5 µA/cm2 (n = 3), P = 0.02 due to FSK. Unlike the nasal epithelium, however, measurements of transepithelial chloride transport across the ileum of FABP-hcftr mice showed complete correction of
electrical responses to FSK. The FABP-hcftr mice showed
a
Isc of 31.7 ± 10.8 µA/cm2 (n = 4) when FSK was added.
These data demonstrate a differential correction of CFTR-
dependent electrical responses between the corrected intestinal epithelium and the uncorrected nasal epithelium in the FABP-hcftr mice.
|
NOS2-Specific Immunostaining in Ileum and Nasal
Epithelium of cftr +/+, cftr
/
, and FABP-hcftr Mice
Ileum and nasal epithelium were excised from cftr +/+,
cftr
/
, and FABP-hcftr mice, fixed, and stained for expression of NOS2. Both tissues have previously been
shown to constitutively express NOS2 in normal mice.
These data were confirmed in cftr +/+ mice where strong
staining for NOS2 was seen in both the ileum and nasal epithelium (Figure 4). Consistent with previous findings (2,
3), neither tissue expressed NOS2 in cftr
/
mice. In
FABP-hcftr mice, where intestinal expression of human
CFTR had been introduced, NOS2 expression was seen
only in the ileum and not in the nasal epithelium. These
data demonstrate that epithelial NOS2 expression is strictly
dependent on the presence of functional CFTR. Thus we
have shown in separate tissues of the same animal differential expression of NOS2 influenced by the presence of CFTR activity.
|
| |
Discussion |
|---|
|
|
|---|
The loss of NO production by airway epithelium has potential consequences that may be directly involved in the progression of CF pathogenesis. Antimicrobial defense mechanisms may be compromised (14, 20, 21), as well as the loss of an important regulatory mechanism associated with the control of transepithelial ion transport (4, 5, 22). It has previously been reported that exhaled NO levels are reduced in patients with CF, particularly from the upper airways (25- 27). Although various mechanisms may contribute to the lack of exhaled NO in CF, it has been demonstrated that expression of immunoreactive NOS2 protein as well as NOS2 mRNA are diminished in CF airway epithelial cells in both mouse and human samples (2, 3).
The goal of this paper was to determine whether NOS2 expression in epithelial cells is directly influenced by CFTR expression and function. We have been able to show in 9/HTEo- cultured human trachea epithelial cells that NOS2 mRNA expression and overall NO production are reduced when CFTR activity is inhibited by overexpressing the CFTR R domain. These cells have previously been shown to lack cAMP-mediated chloride transport (11) and to display characteristic CF phenotypes (28). Inasmuch as the 9/HTEo- cells express CFTR message but CFTR activity is blocked by excess R domain, the results indicate that NOS2 expression is regulated by the presence of active CFTR. The presence of CFTR protein without active chloride transport is insufficient to positively regulate NOS2 expression.
These studies were extended to a mouse model in which
the effects of CFTR function on NOS2 expression could be
directly compared in different epithelial tissues in the same
animal. The cftr +/+ mice exhibit clear epithelial NOS2 expression in both the ileum and in nasal epithelium, whereas
cftr
/
mice lack NOS2 expression in both of these tissues. In FABP-hcftr mice, which express human CFTR in
intestinal epithelium but not in airway epithelium, NOS2 expression is present in the ileum but absent in the nasal
epithelium. The presence of CFTR activity was confirmed
in the ileum of FABP-hcftr by measuring changes in Isc in
response to FSK. The absence of functional CFTR in nasal
epithelium was confirmed by measuring changes in TEPD
in response to chloride-free Ringers and FSK in FABP-hcftr
mice. The FABP-hcftr mice are a unique model system because they have corrected intestinal symptoms associated
with CF mice, but retain CF nasal TEPD characteristics as
well as other phenotypes associated with CF mice, such as
white teeth (29).
Why NOS2 expression is reduced in CF becomes a primary question, especially in an inflammatory disease that
would normally produce conditions favorable to the increased expression of NOS2. Although an exact mechanism needs to be clarified, this work shows that CFTR
function is an important influence in the regulation of
NOS2 expression and NO production. However, it is clear
from other published reports that CFTR is not the only
determining influence in the regulation of NOS2 expression in epithelial cells. It has been shown that constitutive
intestinal NOS2 expression in the mouse is restricted to
the ileum (30). CFTR function, however, has been shown
throughout the intestinal tract (17). What other factors influence NOS2 expression, why different epithelial tissues
differ in constitutive NOS2 expression, and how these characteristics are related to CFTR function are areas that
need further exploration. Similar influence of CFTR on
gene expression has recently been reported with respect to
the production of the cytokine regulated on activation,
normal T cells expressed and secreted (RANTES). Schwiebert and coworkers have demonstrated that the production of RANTES by both airway and pancreatic epithelial cells is dependent on the presence of functional CFTR
(31). This finding is significant because both RANTES and
NOS2 are similarly regulated in that the expression of
both are driven primarily by nuclear factor-
B and the
signal tranducer and activator of transcription 1. These
similarities suggest that there may be a change in cell signaling events that alter the expression of these proteins in
the absence of functional CFTR. The hyperexpression of
various cytokines by CF airway cells in response to infection also indicate that proinflammatory signaling pathways
are intrinsically altered in CF (32, 33).
This manuscript shows that epithelial NOS2 expression is influenced at some level by the presence of active CFTR, and it demonstrates that the reintroduction of functional CFTR into a CF tissue is capable of reversing secondary cellular effects associated with diminished CFTR expression or activity. The FABP-hcftr mice represent an exciting model system in which secondary effects and changes in cell signaling resulting from lost CFTR function can be explored systematically. The examination of how a loss of CFTR function alters inflammatory signaling pathways will illuminate mechanisms responsible for the largely unexplained, multifaceted symptoms associated with CF airway disease. Identification of these pathways and subsequent intervention may lead to powerful new therapeutic options for the treatment of CF.
| |
Footnotes |
|---|
Address correspondence to: Thomas J. Kelley, Ph.D., Dept. of Pediatrics, Case Western Reserve University, 8th floor BRB, 10900 Euclid Ave., Cleveland, OH 44106-4948. E-mail: tjk12{at}po.cwru.edu
(Received in original form April 27, 1999 and in revised form July 7, 1999).
Abbreviations: complementary DNA, cDNA; cystic fibrosis, CF; CF transmembrane conductance regulator, CFTR; wild-type mice, cftr +/+ mice; mice deficient in CFTR expression, cftr
/
mice; fatty acid binding protein, FABP; mice that have had human CFTR introduced to the intestinal
epithelium using the FABP promoter, FABP-hcftr mice; forskolin, FSK;
glyceraldehyde-3-phosphate dehydrogense, GAPDH; a human tracheal
epithelial cell line, 9/HTEo-; short-circuit current, Isc; lipopolysaccharide,
LPS; messenger RNA, mRNA; nitric oxide, NO; inducible NO synthase,
NOS2; phosphate-buffered saline, PBS; cells overexpressing the CFTR R
domain, pCEP-RF; mock-transfected 9/HTEo- cells, pCEP2; polymerase
chain reaction, PCR; regulatory, R; regulated on activation, normal T cells
expressed and secreted, RANTES; reverse transcriptase, RT; transepithelial potential difference, TEPD.
Acknowledgments: This work was supported by a grant from the Cystic Fibrosis Foundation. The authors especially thank Ms. Claudia Garner for preparing tissue sections and P. Bead for technical assistance.
| |
References |
|---|
|
|
|---|
1.
Guo, F. H.,
H. R. Deraeve,
T. W. Rice,
D. J. Stuehr,
F. B. J. M. Thunnisen, and
S. C. Erzurum.
1995.
Continuous nitric oxide synthesis by inducible nitric oxide synthase in normal human airway epithelium in vivo.
Proc. Natl.
Acad. Sci. USA
92:
7809-7813
2. Meng, Q.-H., D. R. Springall, A. E. Bishop, K. Morgan, T. J. Evans, S. Habib, D. C. Gruenert, K. M. Gyi, M. Hodson, M. H. Yacoub, and J. M. Polak. 1998. Lack of inducible nitric oxide synthase in bronchial epithelium: a possible mechanism of susceptibility to infection in cystic fibrosis. J. Pathol. 184: 323-331 [Medline].
3. Kelley, T. J., and M. L. Drumm. 1998. Inducible nitric oxide synthase expression is reduced in cystic fibrosis murine and human airway epithelial cells. J. Clin. Invest. 102: 1200-1207 [Medline].
4.
Elmer, H. L.,
K. G. Brady,
M. L. Drumm, and
T. J. Kelley.
1999.
Nitric oxide-mediated regulation of transepithelial sodium and chloride transport
in murine nasal epithelium.
Am. J. Physiol.
276:
L466-L473
5.
Kamosinska, B.,
M. W. Radomski,
M. Duszyk,
A. Radomski, and
S. F. P. Man.
1997.
Nitric oxide activates chloride currents in human lung epithelial cells.
Am. J. Physiol.
272:
L1098-L1104
6.
Stutts, M. J.,
C. M. Canessa,
J. C. Olsen,
M. Hamrick,
J. A. Cohn,
B. C. Rossier, and
R. C. Boucher.
1995.
CFTR as a cAMP-dependent regulator
of sodium channels.
Science
269:
847-850
7.
Ismailov, I. I.,
M. S. Awayda,
B. Jovov,
B. K. Berdiev,
C. M. Fuller,
J. R. Dedman,
M. A. Kaetzel, and
B. A. Benos.
1996.
Regulation of epithelial
sodium channel by the cystic fibrosis transmembrane conductance regulator.
J. Biol. Chem.
271:
4725-4732
8.
Schwiebert, E. M.,
M. M. Morales,
S. Devidas,
M. E. Egan, and
W. B. Guggino.
1998.
Chloride channel and chloride conductance regulator domains
of CFTR, the cystic fibrosis transmembrane conductance regulator.
Proc.
Natl. Acad. Sci. USA
95:
2674-2679
9.
McNicholas, C. M.,
M. W. Nason,
W. B. Guggino,
E. M. Schwiebert,
S. C. Hebert,
G. Giebisch, and
M. E. Egan.
1997.
A functional CFTR-NBF1 is
required for ROMK2-CFTR interaction.
Am. J. Physiol.
273:
F843-F848
10. Tamai, H., and T. S. Gaginella. 1993. Direct evidence for nitric oxide stimulation of electrolyte secretion in the rat colon. Free Rad. Res. Commun. 19: 229-239 [Medline].
11. Perez, A., K. A. Risma, E. A. Eckman, and P. B. Davis. 1996. Overexpression of R domain eliminates cAMP-stimulated CL-secretion in 9/HTEo- cells in culture. Am. J. Physiol. 217: L85-L92 .
12.
Zhou, L.,
C. R. Dey,
S. E. Wert,
M. D. Duvall,
R. A. Frizzell, and
J. A. Whitsett.
1994.
Correction of lethal intestinal defect in a mouse model of
cystic fibrosis by human CFTR.
Science
266:
1705-1708
13.
Eckman, E.,
C. U. Cotton,
D. M. Kube, and
P. B. Davis.
1995.
Dietary
changes improve survival of CFTR S489X homozygous mutant mouse.
Am. J. Physiol.
269:
L625-L630
14.
Gross, A.,
S. Spiesser,
A. Terraza,
E. C. Rouot, and
J. Dornand.
1998.
Expression and bactericidal activity of nitric oxide synthase in brucella suis-infected murine macrophages.
Infect. Immun.
66:
1309-1316
15.
Grubb, B. R.,
R. N. Vick, and
R. C. Boucher.
1994.
Hyperabsorption of Na
and raised Ca-mediated chloride secretion in nasal epithelia of CF mice.
Am. J. Physiol.
266:
C1478-C1483
16.
Kelley, T. J.,
K. Thomas,
L. J. H. Milgram, and
M. L. Drumm.
1997.
In vivo
activation of the cystic fibrosis transmembrane conductance regulator mutant deltaF508 in murine nasal epithelium.
Proc. Natl. Acad. Sci. USA
94:
2604-2608
17. Steagall, W. K., and M. L. Drumm. 1999. Stimulation of cystic fibrosis transmembrane conductance regulator-dependent short circuit currents across deltaF508 murine intestines. Gastroenterology 116: 1379-1388 [Medline].
18.
Steagall, W. K.,
T. J. Kelley,
R. J. Marsick, and
M. L. Drumm.
1998.
Type II
protein kinase a regulates CFTR in airway, pancreatic, and intestinal cells.
Am. J. Physiol.
274:
C819-C826
19.
Ma, J.,
J. E. Tasch,
T. Tao,
J. Zhao,
J. Xie,
M. L. Drumm, and
P. B. Davis.
1996.
Phosphorylation-dependent block of cystic fibrosis transmembrane
conductance regulator chloride channel by exongenous R domain protein.
J. Biol. Chem.
271:
7351-7356
20. Zhu, L., C. Gunn, and J. S. Beckman. 1992. Bactericidal activity of peroxynitrite. Arch. Biochem. Biophys. 298: 452-457 [Medline].
21. Green, S. J., and C. A. Nacy. 1993. Anitmicrobial and immunopathologic effects of cytokine-induced nitric oxide synthesis. Curr. Opin. Infect. Dis. 6: 384-396 .
22. Rolfe, V. E., and P. J. Milla. 1999. Nitric oxide stimulates cGMP production and electrogenic secretion in caco-2 colonocytes. Clin. Sci. 96: 165-170 [Medline].
23. Stoos, B. A., and J. L. Garvin. 1997. Actions of nitric oxide on renal epithelial transport. Clin. Exp. Pharmacol. Physiol. 24: 591-594 [Medline].
24.
Wilson, K. T.,
A. B. Vaandrager,
J. De Vente,
M. W. Musch,
H. R. De
Jonge, and
E. B. Chang.
1996.
Production and localization of cGMP and
PGE2 in nitroprusside-stimulated rat colonic ion transport.
Am. J. Physiol.
270:
C832-C840
25. Dotsch, J., S. Demirakca, H. G. Terbrack, G. Hulls, W. Rascher, and P. G. Kuhl. 1996. Airway nitric oxide in asthmatic children and patients with cystic fibrosis. Eur. Respir. J. 9: 2537-2540 [Abstract].
26. Grasemann, H., E. Michler, M. Wallot, and F. Ratjen. 1997. Decreased concentration of exhaled nitric oxide (NO) in patients with cystic fibrosis. Pediatr. Pulmonol. 24: 173-177 [Medline].
27. Lundberg, J. O., S. L. Nordvall, E. Weitzberg, H. Kollberg, and K. Alving. 1997. Exhaled nitric oxide in paediatric asthma and cystic fibrosis. Arch. Dis. Child 75: 323-326 [Abstract].
28.
Bryan, R.,
D. Kube,
A. Perez,
P. Davis, and
A. Prince.
1998.
Overproduction of the CFTR R domain leads to increased levels of asialoGM1 and increased Pseudomonas aeruginosa binding by epithelial cells.
Am. J. Respir.
Cell. Mol. Biol.
19:
269-277
29.
Wright, J. T.,
C. L. Kiefer,
K. I. Hall, and
B. R. Grubb.
1996.
Abnormal
enamel development in a cystic fibrosis transgenic mouse model.
J. Dent.
Res.
75:
966-973
30.
Hoffman, R. A.,
G. Zhang,
N. C. Nussler,
S. L. Gleixner,
H. R. Ford,
R. L. Simmons, and
S. C. Watkins.
1997.
Constitutive expression of inducible nitric oxide synthase in the mouse ileal mucosa.
Am. J. Physiol.
272:
G383-G392
31.
Schweibert, L. M.,
K. Estell, and
S. M. Propst.
1999.
Chemokine expression
in CF epithelia: implications for the role of CFTR in RANTES expression.
Am. J. Physiol.
276:
C700-C710
32.
Tabary, O.,
J. M. Zahm,
J. Hinnrasky,
J. P. Coutil,
P. Cornillet,
M. Guenounou,
D. Gaillard,
E. Puchelle, and
J. Jacqout.
1998.
Selective up-regulation of chemokine IL-8 expression in cystic fibrosis bronchial gland cells
in vivo and in vitro.
Am. J. Pathol.
153:
921-930
33. van Heeckeren, A., R. Walenga, M. W. Konstan, T. Bonfield, P. B. Davis, and T. Ferkol. 1997. Excessive inflammatory response of cystic fibrosis mice to bronchopulmonary infection with pseudomonas aeruginosa. J. Clin. Invest. 100: 2810-2815 [Medline].
This article has been cited by other articles:
![]() |
S. D. Sagel, J. F. Chmiel, and M. W. Konstan Sputum Biomarkers of Inflammation in Cystic Fibrosis Lung Disease Proceedings of the ATS, August 1, 2007; 4(4): 406 - 417. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Guilbault, Z. Saeed, G. P. Downey, and D. Radzioch Cystic Fibrosis Mouse Models Am. J. Respir. Cell Mol. Biol., January 1, 2007; 36(1): 1 - 7. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. E. Machen Innate immune response in CF airway epithelia: hyperinflammatory? Am J Physiol Cell Physiol, August 1, 2006; 291(2): C218 - C230. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Moeller, F Horak Jr, C Lane, D Knight, A Kicic, S Brennan, P Franklin, J Terpolilli, J H Wildhaber, and S M Stick Inducible NO synthase expression is low in airway epithelium from young children with cystic fibrosis Thorax, June 1, 2006; 61(6): 514 - 520. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Guilbault, J. P. Novak, P. Martin, M.-L. Boghdady, Z. Saeed, M.-C. Guiot, T. J. Hudson, and D. Radzioch Distinct pattern of lung gene expression in the Cftr-KO mice developing spontaneous lung disease compared with their littermate controls Physiol Genomics, April 13, 2006; 25(2): 179 - 193. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Bensalem, A. P. Ventura, B. Vallee, J. Lipecka, D. Tondelier, N. Davezac, A. D. Santos, M. Perretti, A. Fajac, I. Sermet-Gaudelus, et al. Down-regulation of the Anti-inflammatory Protein Annexin A1 in Cystic Fibrosis Knock-out Mice and Patients Mol. Cell. Proteomics, October 1, 2005; 4(10): 1591 - 1601. [Abstract] [Full Text] [PDF] |
||||
![]() |
D W Reid, J C Ojoo, S A Mulrennan, J A Kastelik, A H Morice, and A E Redington Bacterial denitrification, nitric oxide and airway pH in CF Thorax, July 1, 2005; 60(7): 614 - 614. [Full Text] [PDF] |
||||
![]() |
J C Ojoo, S A Mulrennan, J A Kastelik, A H Morice, and A E Redington Exhaled breath condensate pH and exhaled nitric oxide in allergic asthma and in cystic fibrosis Thorax, January 1, 2005; 60(1): 22 - 26. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. M. White, D. A. Corey, and T. J. Kelley Mechanistic Similarities between Cultured Cell Models of Cystic Fibrosis and Niemann-Pick Type C Am. J. Respir. Cell Mol. Biol., November 1, 2004; 31(5): 538 - 543. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. van Heeckeren, A. Scaria, M. D. Schluchter, T. W. Ferkol, S. Wadsworth, and P. B. Davis Delivery of CFTR by adenoviral vector to cystic fibrosis mouse lung in a model of chronic Pseudomonas aeruginosa lung infection Am J Physiol Lung Cell Mol Physiol, April 1, 2004; 286(4): L717 - L726. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. E. Kreiselmeier, N. C. Kraynack, D. A. Corey, and T. J. Kelley Statin-mediated correction of STAT1 signaling and inducible nitric oxide synthase expression in cystic fibrosis epithelial cells Am J Physiol Lung Cell Mol Physiol, December 1, 2003; 285(6): L1286 - L1295. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. E. A. Darling and T. J. Evans Effects of Nitric Oxide on Pseudomonas aeruginosa Infection of Epithelial Cells from a Human Respiratory Cell Line Derived from a Patient with Cystic Fibrosis Infect. Immun., May 1, 2003; 71(5): 2341 - 2349. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Estell, G. Braunstein, T. Tucker, K. Varga, J. F. Collawn, and L. M. Schwiebert Plasma Membrane CFTR Regulates RANTES Expression via Its C-Terminal PDZ-Interacting Motif Mol. Cell. Biol., January 15, 2003; 23(2): 594 - 606. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Kelley, H. L. Elmer, and D. A. Corey Reduced Smad3 Protein Expression and Altered Transforming Growth Factor-beta 1-Mediated Signaling in Cystic Fibrosis Epithelial Cells Am. J. Respir. Cell Mol. Biol., December 1, 2001; 25(6): 732 - 738. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. G. Brady, T. J. Kelley, and M. L. Drumm Examining basal chloride transport using the nasal potential difference response in a murine model Am J Physiol Lung Cell Mol Physiol, November 1, 2001; 281(5): L1173 - L1179. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. McMorran, J. S. Palmer, D. P. Lunn, D. Oceandy, E. O. Costelloe, G. R. Thomas, D. A. Hume, and B. J. Wainwright G551D CF mice display an abnormal host response and have impaired clearance of Pseudomonas lung disease Am J Physiol Lung Cell Mol Physiol, September 1, 2001; 281(3): L740 - L747. [Abstract] [Full Text] [PDF] |
||||
![]() |
H E Elphick, E A G Demoncheaux, S Ritson, T W Higenbottam, and M L Everard Exhaled nitric oxide is reduced in infants with cystic fibrosis Thorax, February 1, 2001; 56(2): 151 - 152. [Abstract] [Full Text] |
||||
![]() |
J. H. Widdicombe Yet Another Role for the Cystic Fibrosis Transmembrane Conductance Regulator Am. J. Respir. Cell Mol. Biol., January 1, 2000; 22(1): 11 - 14. [Full Text] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Proc. Am. Thorac. Soc. | Am. J. Respir. Crit. Care Med. |